University of Oxford
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Outcomes of Neonatal Resuscitation
Completed
- Conditions
- Neonatal Resuscitation
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 15073
- Registration Number
- NCT02840682
- Locations
- 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand
The Experience of TYAC Offered Ovarian Tissue Cryopreservation
Completed
- Conditions
- FertilityCancer
- Interventions
- Other: Interviews
- First Posted Date
- 2016-07-12
- Last Posted Date
- 2019-10-24
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 12
- Registration Number
- NCT02830061
Low dosE GlibENclamide in Diabetes Part A
- First Posted Date
- 2016-07-12
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 16
- Registration Number
- NCT02830048
- Locations
- 🇬🇧
Clinical Research Unit, OCDEM, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
The Oxford Pain, Activity and Lifestyle (OPAL) Cohort Study
- Conditions
- Low Back Pain
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 5409
- Registration Number
- NCT02820571
- Locations
- 🇬🇧
University of Oxford, Botnar Research Centre, Oxford, Oxfordshire, United Kingdom
Quality of Life Measures in Patients With Retinal Degeneration
Completed
- Conditions
- Retinal Degeneration
- Interventions
- Other: QuestionnaireOther: Computerised contrast sensitivity function test
- First Posted Date
- 2016-06-27
- Last Posted Date
- 2018-11-13
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 90
- Registration Number
- NCT02814435
- Locations
- 🇬🇧
Oxford Eye Hospital, Oxford, United Kingdom
P.Vivax Treatment Trial
Phase 1
Completed
- Conditions
- Plasmodium Vivax
- Interventions
- Drug: Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ)Drug: Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ) placebo
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 41
- Registration Number
- NCT02802813
- Locations
- 🇱🇦
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Vientiane, Lao People's Democratic Republic
Child Follow-up Until 2 Years
Completed
- Conditions
- MalariaPregnancy
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 201
- Registration Number
- NCT02800109
- Locations
- 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand
Molecular Signature Pregnancy
Completed
- Conditions
- Pregnancy
- First Posted Date
- 2016-06-13
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 430
- Registration Number
- NCT02797327
- Locations
- 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand
Glutathione Levels and Compulsivity
Not Applicable
Completed
- Conditions
- Compulsive BehaviorAnorexia Nervosa
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-06-09
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 23
- Registration Number
- NCT02794389
- Locations
- 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom
Mindfulness for Irritable Bowel Syndrome
Not Applicable
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Behavioral: Mindfulness Based Cognitive Therapy (MBCT)Behavioral: Waiting Period
- First Posted Date
- 2016-06-09
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 67
- Registration Number
- NCT02794376
© Copyright 2025. All Rights Reserved by MedPath